SEC fundamentals

Latigo Biotherapeutics, Inc. (LTGO)

as filed in 10-Q FY2026, period ended Sep 30, 2026 · updated Nov 7, 2026
Total Assets
$408.5M
Stockholders' Equity
$394.0M
Cash & Equivalents
$401.2M
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Sep 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Sep 30, 2026, Latigo Biotherapeutics, Inc. reported net income of -$20.9M and total assets of $408.5M. Every figure below is taken directly from Latigo Biotherapeutics, Inc.'s SEC filings: each links to the source document on EDGAR.

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KNov 5, 2026on EDGAR ↗
10-QNov 5, 2026on EDGAR ↗
10-QSep 3, 2026on EDGAR ↗
8-KSep 3, 2026on EDGAR ↗
8-KAug 10, 2026on EDGAR ↗
S-1Jul 17, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Sep 30, 2026 · 10-Q

Total Assets$408.5Msource ↗
Stockholders’ Equity$394.0Msource ↗
Cash & Equivalents$401.2Msource ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Sep 30, 2026

Revenue—source ↗
Net Income-$20.9Msource ↗
Operating Income-$22.9Msource ↗
Gross Profit—source ↗
Cost of Revenue—source ↗
R&D Expense$17.5Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Sep 30, 2026

EPS (diluted)$-0.55source ↗
EPS (basic)$-0.55source ↗
Shares Outstanding66.3Msource ↗
Cash from Operations-$19.5Msource ↗
Cash from Financing$365.8Msource ↗
Cash from Investing-$36,000source ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
1
Sells
0
Net shares
+140.0K

Restatement history

Point-in-time

No material restatements detected across 0 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.

Deeper fundamentals

A free API key reaches LTGO’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Starter extends the ratios to 20 quarters and adds the Piotroski F-score and accruals quality score; Analyst extends the trajectory to up to 20 years. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Starter removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/LTGO

MCP tool: get_sec_fundamentals ticker=LTGO

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/LTGO/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=LTGO as_of=YYYY-MM-DD

Quarter-end prices derived from SEC filings, with their sources and splits
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/prices/LTGO/history?frequency=quarter

MCP tool: get_sec_price_history ticker=LTGO frequency=quarter

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/LTGO/history

MCP tool: get_fundamentals_history ticker=LTGO

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/LTGO

MCP tool: get_financial_health ticker=LTGO

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.